Edward Oliva's Colleagues at QED Therapeutics
Edward Oliva's Contact Details
HQ
650-231-4088
650-231-4088
Location
Company
QED Therapeutics
QED Therapeutics
Edward Oliva's Company Details
QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.
Frequently Asked Questions about Edward Oliva
Edward Oliva currently works for QED Therapeutics.
Edward Oliva's role at QED Therapeutics is Senior Clinical Program Manager.
Edward Oliva's email address is ***@qedtx.com. To view Edward Oliva's full email address, please signup to ConnectPlex.
Edward Oliva works in the Biotechnology industry.
Edward Oliva's colleagues at QED Therapeutics are Sudesh PhD, Quoc M., Ai Li, Craig Berman, Elena Muslimova, Dan Mulreany, Robyn Leary and others.
Edward Oliva's phone number is 650-231-4088